🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GW642444 and GSK233705 are in development for treatment of Chronic Obstruct...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-11-10
Trial ID
NCT00783003
Treatments Being Tested
The study will assess the corrected QT (QTc) effects (electrocardiogram \[E...
Status
Completed
Location
Celerion
Start Date
2021-06-11
Trial ID
NCT05293171
This is a Phase 1, single centre, randomised, double blind (except for moxi...
Status
Completed
Location
Covance Clinical Research Unit (CRU) Ltd
Start Date
2018-06-15
Trial ID
NCT03577275
Treatments Being Tested
The purpose of this study is to evaluate the effect of OMS302 on the signs ...
Status
Terminated
Location
Omeros Investigational Site
Start Date
2014-02
Trial ID
NCT02093689
Treatments Being Tested
The primary objective of the study is to evaluate the neurocognitive effect...
Status
Completed
Location
Multiple Locations
Start Date
2008-07
Trial ID
NCT00736931
Treatments Being Tested
The purpose of this study is to determine the safety, efficacy and pharmaco...
Status
Completed
Location
Multiple Locations
Start Date
2012-04
Trial ID
NCT01579565
The study is intended to characterize the lung function profile of BI1744 i...
Status
Completed
Location
1222.39.32003 Boehringer Ingelheim Investigational Site
Start Date
2010-01
Trial ID
NCT01040689
Randomized, placebo-controlled double-blind, crossover design study; 116 su...
Status
Completed
Location
Multiple Locations
Start Date
2008-12
Trial ID
NCT00874120
Treatments Being Tested
This study will involve the use of a new compound, GW642444 that is being d...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-08
Trial ID
NCT00519376
This is a randomized, double-blind, double-dummy, placebo- and active-contr...
Status
Completed
Location
Vallon Investigational Site
Start Date
2020-10-05
Trial ID
NCT04647903
Treatments Being Tested